Pēdējā atjaunošana :
27/11/2024
Infostab
Saraksti
Kopsavilkums
Meklēt saderības
Y-savienojuma saderības tabula
Literatūras saraksts
pētniecības grupas
valistab
plakāts
Savienojumi
sponsori
Autori
Lietošanas instrukcija
Newsletter
Morphine hydrochloride
Ķīmiskā uzbūve
Oriģinālais nosaukums
Tirdzniecības nosaukumi ir apzīmējoši un palīgvielas var atšķirties dažādām valstīm un laboratorijām
Amidiaz
Argentīna
Analfin
Meksika
Morfin
Norvēģija, Zviedrija
Morfina clorhidrato
Čīle, Ekvadora, Itālija, Peru
Morfine
Holande
Morphin
Somija
Morphine
Beļģija, Francija
Stellorphine
Beļģija
Vendal
Austrija
Literatūras saraksts : Morphine hydrochloride
tips
publicēšana
186
Žurnāls
Swart EL, Mooren RAG, Van Loenen AC.
Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
219
Žurnāls
Oustric-Mendes AC, Huart B, Le Hoang MD, Perrin-Rosset M, Pailler FM, Darbord JC, Prognon, Gard C, Pradeau D.
Study protocol : stability of morphine injected without preservative, delivered with a disposable infusion device.
J Clin Pharm Ther 1997 ; 22: 283-290.
346
Žurnāls
Wulf H, Gleim M, Mignat C.
The stability of mixtures of morphine hydrochloride, bupivacaine hydrochloride, and clonidine hydrochloride in portable pump reservoirs for the management of chronic pain syndromes.
J Pain Symptom Manage 1994 ; 9: 308-311.
515
Žurnāls
Le Hoang MD, Sarbach C, Prognon P, Delvordre P, Mignot A, Pradeau D.
Stability of morphine hydrochloride solutions in portable single-use PCA systems. Additives leaching into the morphine solutions.
J Pharm Clin 1998 ; 17: 35-39.
679
Žurnāls
Roos PJ, Glerum JH, Meilink JW.
Stability of morphine hydrochloride in a portable pump reservoir.
Pharm Weekbl [Sci] 1992 ; 14: 23-26.
1062
Žurnāls
Vermeire A, Remon JP.
The stability of morphine and the stability of concentrated morphine solutions in glass, polypropylene syringes and PVC containers.
Int J Pharm 1997 ; 146: 213-223.
1228
Žurnāls
Allen LV, Stiles ML.
Compatibility of various admixtures at Y-injection sites of intravenous administration sets. Part2.
Am J Hosp Pharm 1981 ; 38: 380-381.
1264
Žurnāls
Truelle-Hugon B, Tourette G, Couineaux B, Gache-Charrette C.
Study of Lavoisier morphine chlorhydrate in different active perfusion systems after reconstitution in different solvents.
Ann Pharm Fr 1997 ; 55: 216-223.
1506
Žurnāls
Lopez-Cabezas C, Guerrero L, Molas G, Anglada H, Soy D.
Physicochemical compatibility of high concentration drugs usually Y-site administered in intensive care units.
EJHP 2015 ;22:107-112.
1508
Žurnāls
Voirol P, Berger-Gryllaki M, Pannatier A, Eggimann P, Sadeghipour F.
Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU.
EJHP 2015 ;22:123-124.
1513
Laboratorija
Quinupristine / dalfopristine (Synercid®) - Résumé des caractéristiques du produit
Monarch Pharmaceuticals Ireland 2006
1757
Žurnāls
Schrijvers D, Tai-Apin C, De Smet MC, Cornil P, Vermorken JB, Bruyneel P.
Determination of compatibility and stability of drugs used in palliative care.
J Clin Pharm Ther 1998 ; 23: 311-314.
1842
Žurnāls
Sadjack A, Wintersteiger R.
Compatibility of morphin, baclofen, floxuridine and fluorouracil in an implantable infusion pump.
Arzneimittel Forschung 1995 ; 45: 93-98.
1866
Žurnāls
Vermeire A, Remon JP.
Compatibility and stability of morphine in binary admixtures with haloperidol, midazolam, dexamethasone or methylprednisolone.
Int J Pharm 1998 ; 174: 157-177.
1885
Žurnāls
Essink-Tjebbes CM, Burger DM, Beelen, Wuis EW, Heckster YA.
Long-term stability of morphine and bupivacaine mixture for spinal use.
Pharm World Sci 1999 ; 21: 144-146.
1966
Žurnāls
Barcia E, Reyes R, Azuara L, Sànchez Y, Negro S.
Stability and compatibility of binary mixtures of morphine hydrochloride with hyoscine-n-butyl bromide.
Support Care Cancer 2005 ; 13, 4: 239-245.
1971
Žurnāls
Azuara ML, Sanchez Y, Reyes R, Barcia E.
Physical compatibility and in vivo evaluation of drug mixtures forsubcutaneous infusion to cancer patients in palliative care.
Support Care Cancer 2001
2055
Žurnāls
Negro S, Reyes R, Azuara ML, Sanchez Y, Barcia E.
Morphine, haloperidol and hyoscine N-butyl bromide combined in sc infusion solutions : compatibility and stability evaluation in terminal oncology patients.
Int J Pharm 2006 ; 307: 278-284.
2262
Žurnāls
Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2362
plakāts
Trittler R, M?ller S, Esteban M.
Morphin-Haloperidol mischungen in PCA Pumpen : Kompatibel?
ADKA Congress 2009 2009
2363
plakāts
M?ller S, Trittler R, Schubert R, von Hornstein W.F, Strehl E.
Morphin-Metamizol mischungen zur kontinuierlichen parenteralen applikation : Sind sie immer inkompatibel?
ADKA Congress 2006
3169
Žurnāls
Raffaeli W, Pari G, Visani L et al.
Experimentation about precipitation of pharmacological association: morphine and ketorolac.
Pain Clinic 1999 ; 11: 213-216.
3332
Laboratorija
Tigecycline (Tigacyl®) - Summary of Product characteristics
Pfizer 2012
3415
Žurnāls
d?Hayer B, Vieillard V, Astier A, Paul M
Stability-Indicating HPLC Assay and Stability Study Over Two Years of Morphine Hydrochloride Diluted Solutions in Polypropylene Syringes
Pharmaceut Anal Acta 2013 ; 4: 205
3470
Žurnāls
Destro M, Ottolini L, Vicentini L, Boschetti S.
Physical compatibility of binary and tertiary mixtures of morphine and methadone with other drugs for parenteral administration in palliative care.
Support Care Cancer 2012 ; 20: 2501-2509.
3474
Laboratorija
Fluorouracil - Summary of Product Characteristics
Accord Healthcare Limited 2009
3504
Laboratorija
Parecoxib (Dynastat®) - Summary of Product Characteristics
Pfizer 2012
3572
Žurnāls
Hecq J-D, Godet M, Gillet P, Jamart J, Galanti L.
Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C.
Int J Pharm Compound 2014 ; 18, 1 : 78-82.
3675
Laboratorija
Thiopental sodium - Summary of Product Characteristics
Archimedes Pharma UK Ltd 2015
3791
plakāts
Sadou Yaye H, Burtet E, Hamel C, Aljhni R, Gard C, Tilleul P.
Étude de la compatibilité physico-chimique du phloroglucinol injectable durant les mélanges au sein des tubulures en Y.
Apifh Congress, Paris November 2014 2014
3934
Laboratorija
Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit
GlaxoSmithKline Laboratoire 2016
3976
Žurnāls
Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B.
Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
4034
Žurnāls
Chen F-C, Fang B-X, Li P, Zheng F, Shi X-Y.
Compatibility and stability of lornoxicam with morphine, tramadol or fentanyl in infusion solutions.
Afr J Pharm Pharmacol 2012 ;27,6:2055-2060
4051
Žurnāls
Robert J, Sorrieul J, Kieffer H, Folliard C, Gibory V, Dupoiron D, Devys C.
Stability study of morphine and baclofen solution in polypropylene syringes.
Pharmaceutical Technology in Hospital Pharmacy 2017 ;2,4:173-180
4332
plakāts
Compatibilité de Glycophos® avec d’autres médicaments administrés en perfusion aux soins intensifs (SI)
Compatibilité de Glycophos® avec d’autres médicaments administrés en perfusion aux soins intensifs (SI).
JFSPH 2019 2019
4404
plakāts
Müller U, Haller F, Wiedemeier P, Steuer C.
Compatibility studies of seven commonly used drugs for parenteral administration in palliative care.
JFSPH 2019 2019
4538
Žurnāls
Campbell A, Petrovski M, Senarathna G, Mukadam ,Strunk T, Batty K.
Compatibility of pentoxifylline and parenteral medications.
Archives of Disease in Childhood 2020 ; 105: 395-397.
4543
Žurnāls
Senarathna G, Strunk T, Petrovski M, Batty K.
Physical compatibility of pentoxifylline and intravenous medications.
Archives of Disease in Childhood 2018 ;104:292–295.
4545
Žurnāls
Kondo M, Nagano M, Yoshida M, Yoshida N, Tagui N, Yoshida M, Sugaya K, Takase H.
Physical compatibility of nafamostat with analgesics, sedatives, and muscle relaxants for coronavirus disease treatment.
Journal of Nippon Medical school 2021
4643
Žurnāls
Catry E, Colsoul M-L, Closset M, Nyssen C, Hubert J, Soumoy L, Bihin B, Jamart J, Hecq J-D, Galanti L.
Evaluation of 30-day stability of morphine hydrochloride and clonidine at high and low concentrations in polypropylene syringes.
EJHP 2021
4651
Žurnāls
De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pascual P, De Miguel M, Campino A.
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
Eur J Pedia 2021 ;180,1169–1176.
4664
Žurnāls
Harder M, Fiegl-Lechner A, Oberacher H, Horvath U.E.I, Schlager A, Jeske M, Kerndler S, Schüllner F, Bonn G.F, Rainer M.
Stability evaluation of morphine, hydromorphone, metamizole and esketamine containing analgesic mixtures applied for patient-controlled analgesia in hospice and palliative care.
Biomed Chromatogr 2022 ;e5340.
4667
Žurnāls
Ping L, juan H, Li R-L, Feng Z-Y, Zhou X-J, Liu M-F, Jing B, Jian L.
Stability of Hydromorphone Hydrochloride and Morphine under Different Clinical Infusion Conditions.
Int J Pharm Pharm Sci 2019 ;81(6):1140-114
4768
Žurnāls
Kondo M, Genpei M, Watanabe K, Yoshida M, Tagui N, Fukao S, Sugaya K, Takase H.
Y-site injection physical compatibility of remdesivr with select intravenous drugs used in palliative care and for treating coronavirus disease 2019.
Journal of Nippon Medical school 2023
4831
Žurnāls
Nezvalova-Henriksen K, Huseby Holm T, Nilsson N, Kjønniksen I, Tho I.
Frequently acquired drugs in neonatal intensive care and their physical compatibility.
Acta Paediatr 2022 ;111:2307–2314.
4832
Žurnāls
Nilsson N, Storesund I, Tho I, Nezvalova‑Henriksen K.
Co‑administration of drugs with parenteral nutrition in the neonatal intensive care unit—physical compatibility between three components.
Eur J Pedia 2022 ; 181:2685–2693.
4837
Žurnāls
De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T.
Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings.
Eur J Clin Pharmacol 2024 ; 80:1079–1087.
Mentions Légales